S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon

Cogent Biosciences (COGT) Short Interest Ratio & Short Volume

$6.71
+0.10 (+1.51%)
(As of 04/19/2024 ET)

Cogent Biosciences Short Interest Data

Current Short Volume
10,840,000 shares
Previous Short Volume
9,630,000 shares
Change Vs. Previous Month
+12.56%
Dollar Volume Sold Short
$72.84 million
Short Interest Ratio / Days to Cover
5.0
Last Record Date
March 31, 2024
Outstanding Shares
95,613,000 shares
Percentage of Shares Shorted
11.34%
Today's Trading Volume
1,518,301 shares
Average Trading Volume
1,284,336 shares
Today's Volume Vs. Average
118%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cogent Biosciences ?

Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

COGT Short Interest Over Time

COGT Days to Cover Over Time

COGT Percentage of Float Shorted Over Time

Cogent Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72
3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05
2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00
2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88
1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43
1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06
12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88
12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88
11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67
11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68
10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16
10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52
9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75
9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76
8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21
8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29
7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99
7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53
6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84
6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61
5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74
5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90
4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76
4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27
3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79
3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16
2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23
2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72
1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06
1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03
12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56
12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96
11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58
11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71
10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65
10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61
9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92
9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43
8/31/20223,220,000 shares $53.10 million -30.6%N/A1 $16.49
8/15/20224,640,000 shares $67.79 million -10.1%N/A1.5 $14.61
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

COGT Short Interest - Frequently Asked Questions

What is Cogent Biosciences' current short interest?

Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 10,840,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest.

What is a good short interest ratio for Cogent Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 5.0. Learn More on Cogent Biosciences's short interest ratio.

Which institutional investors are shorting Cogent Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cogent Biosciences: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Cogent Biosciences' short interest increasing or decreasing?

Cogent Biosciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 10,840,000 shares, an increase of 12.6% from the previous total of 9,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Cogent Biosciences' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Cogent Biosciences: Wave Life Sciences Ltd. (2.94%), Stoke Therapeutics, Inc. (15.01%), Dianthus Therapeutics, Inc. (6.46%), Celcuity Inc. (6.11%), Gracell Biotechnologies Inc. (1.64%), Icosavax, Inc. (0.99%), Corbus Pharmaceuticals Holdings, Inc. (4.58%), Shattuck Labs, Inc. (4.40%), Harpoon Therapeutics, Inc. (4.31%), Solid Biosciences Inc. (3.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Cogent Biosciences stock?

Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cogent Biosciences?

A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further.

How often is Cogent Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:COGT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners